Evidence-Based Cancer Therapies Aren't Covered by Insurance — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO) have jointly developed clinical practice guidelines for integrative oncology, with recommendations embedded throughout the National Comprehensive Cancer Network (NCCN) symptom management pathways.
- Acupuncture is recommended for cancer pain and chemotherapy-induced nausea, while mindfulness-based interventions are endorsed for anxiety, depression, and fatigue, and exercise and nutrition counseling are described as foundational rather than optional in cancer care.
- Cohen's team published findings in Cancer Medicine showing a standardized biofield therapy protocol significantly inhibited growth and invasiveness of pancreatic cancer cells in vitro and reduced liver metastasis in mouse models, with changes in mitochondrial structure, cell cycle regulation, and the FOXM1 oncogenic pathway.
- The U.S. Department of Veterans Affairs already includes reiki, healing touch, and therapeutic touch among its integrative health offerings, and major U.S. hospitals are integrating these approaches into routine supportive care, the article states.
- Coverage remains fragmented: two patients with identical diagnoses can receive different supportive care based solely on geography, insurer, or employer-negotiated benefits, the article argues, because many insurers still classify integrative therapies as optional rather than evidence-based.
- Cohen contends that acupuncture sessions cost far less than nerve blocks and group mindfulness programs cost a fraction of an emergency department visit for uncontrolled symptoms, making non-coverage economically irrational as well as clinically inequitable.
- Medicare, Medicaid, and private insurers should update coverage policies to reflect NCCN and SIO-ASCO recommendations, the opinion concludes, arguing the barrier is now political will rather than scientific credibility.
Why it matters: Cancer patients are being told to pay out of pocket for therapies that the field's two leading guideline bodies already endorse, creating a two-tiered system where access depends on geography and insurer rather than clinical need. Mandating coverage alignment with NCCN and SIO-ASCO guidelines would immediately expand access to acupuncture, mindfulness, and nutrition counseling for the millions of Americans undergoing cancer treatment each year.
Ask SkimNews
